Mainz Biomed
Mainz BioMed is a molecular genetic diagnostics company that develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's molecular genetic diagnostic tools focus on early cancer detection. It markets ColoAlert, a non-invasive home test for colorectal cancer combining DNA and fecal immunochemical analysis, commercially available across Europe and the UAE. The company is advancing its pipeline with PancAlert, a PCR-based stool test for early pancreatic cancer, and has initiated pivotal FDA registration studies for a next-generation colorectal test using proprietary mRNA biomarkers, AI algorithms, and FIT components.
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Mainz Biomed use?+
Mainz Biomed uses 10 technologies including Framer Motion, Svelte, Umami.
What industry is Mainz Biomed in?+
Mainz Biomed operates in the Biotechnology industry.
Where is Mainz Biomed based?+
Mainz Biomed is headquartered in Germany.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026